tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LCTX Stock Latest News

Promising Developments and Strong Financial Position Support Buy Rating for Lineage Cell Therapeutics
RatingsPromising Developments and Strong Financial Position Support Buy Rating for Lineage Cell Therapeutics
10d ago
LCTX
Lineage Cell Therapeutics: Strong Financials and Promising Clinical Data Drive Buy Rating
PremiumRatings
Lineage Cell Therapeutics: Strong Financials and Promising Clinical Data Drive Buy Rating
11d ago
LCTX
Lineage Cell Therapeutics Reports Q2 2025 Progress and Challenges
PremiumCompany Announcements
Lineage Cell Therapeutics Reports Q2 2025 Progress and Challenges
11d ago
LCTX
Lineage Cell Therapeutics reports Q2 EPS (13c), consensus (3c)
PremiumThe Fly
Lineage Cell Therapeutics reports Q2 EPS (13c), consensus (3c)
11d ago
LCTX
Lineage Cell Therapeutics: Buy Rating Affirmed Amid OPC1 Program Milestone and Strategic Financial Positioning
PremiumRatings
Lineage Cell Therapeutics: Buy Rating Affirmed Amid OPC1 Program Milestone and Strategic Financial Positioning
17d ago
LCTX
LCTX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsLCTX Upcoming Earnings Report: What to Expect?
19d ago
LCTX
Buy Rating Affirmed for Lineage Due to Breakthrough in OPC1 Delivery for Chronic SCI Patients
Premium
Ratings
Buy Rating Affirmed for Lineage Due to Breakthrough in OPC1 Delivery for Chronic SCI Patients
20d ago
LCTX
Lineage Cell Therapeutics doses first patient in DOSED study
Premium
The Fly
Lineage Cell Therapeutics doses first patient in DOSED study
20d ago
LCTX
Lineage Therap Holds Annual Meeting, Elects Directors
PremiumCompany Announcements
Lineage Therap Holds Annual Meeting, Elects Directors
2M ago
8K
LCTX
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
ACB
CAN
Buy Rating Affirmed for Lineage Cell Therapeutics: Promising OpRegen Data and Long-term Potential
PremiumRatings
Buy Rating Affirmed for Lineage Cell Therapeutics: Promising OpRegen Data and Long-term Potential
2M ago
LCTX
Lineage Therap Reports Promising OpRegen Study Results
PremiumCompany Announcements
Lineage Therap Reports Promising OpRegen Study Results
2M ago
8K
LCTX
Lineage Cell Therapeutics announces RG6501 study meets primary endpoint at CTS
PremiumThe FlyLineage Cell Therapeutics announces RG6501 study meets primary endpoint at CTS
2M ago
CHRO
LCTX
Lineage Cell Therapeutics’ Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
Lineage Cell Therapeutics’ Earnings Call Highlights Progress and Challenges
3M ago
LCTX
Lineage Cell Therapeutics: Strategic Partnerships and Promising Developments Justify Buy Rating
Premium
Ratings
Lineage Cell Therapeutics: Strategic Partnerships and Promising Developments Justify Buy Rating
3M ago
LCTX
Promising Pipeline and Strategic Partnerships Drive Buy Rating for Lineage Cell Therapeutics
PremiumRatings
Promising Pipeline and Strategic Partnerships Drive Buy Rating for Lineage Cell Therapeutics
3M ago
LCTX
Lineage Cell Therapeutics Reports Q1 2025 Financials
PremiumCompany Announcements
Lineage Cell Therapeutics Reports Q1 2025 Financials
3M ago
LCTX
Lineage Cell Therapeutics reports Q1 EPS (2c), consensus (3c)
PremiumThe Fly
Lineage Cell Therapeutics reports Q1 EPS (2c), consensus (3c)
3M ago
LCTX
Lineage Cell announces 36-month results for Phase 1/2a trial of RG6501
PremiumThe Fly
Lineage Cell announces 36-month results for Phase 1/2a trial of RG6501
3M ago
LCTX
Is LCTX a Buy, Before Earnings?
PremiumPre-EarningsIs LCTX a Buy, Before Earnings?
3M ago
LCTX
Lineage Cell Therapeutics price target lowered to $3 from $4 at B. Riley
Premium
The Fly
Lineage Cell Therapeutics price target lowered to $3 from $4 at B. Riley
5M ago
LCTX
Optimistic Outlook for Lineage Cell Therapeutics: Buy Rating Supported by Financial Stability and Strategic Developments
Premium
Ratings
Optimistic Outlook for Lineage Cell Therapeutics: Buy Rating Supported by Financial Stability and Strategic Developments
5M ago
LCTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >